Creating
a ­#Biobased­Future
#Future­Food
#Genome­Editing­Solutions
#Plantbased­Sweeteners

The future is bio-based

Industrial biotechnology is our profession. Finding solutions for sustainable products and processes is our passion. Together with our customers, we are creating a #biobasedFuture.


A fermentation plant at Biocatalysts
© Biocatalysts

What we do

We enable industry partners to make products and processes more sustainable: with optimized enzymes, high-performance microorganisms and bioactive compounds.

Products and markets


How we do it

Our interdisciplinary, agile approach, scientific and application expertise, and a broad portfolio of biotech methods are key to our innovative solutions.

Solutions

Why work with us?

As a solution provider for industry we bring customer projects to a fast and successful outcome.

BRAIN CRISPR
© BRAIN Biotech
GENOME EDITING

Genome editing tools to bring your projects to success rapidly and cost-efficiently

With our alternative genome editing tools, we bring your projects to success rapidly and cost-efficiently

We CRISPR for You
CUSTOMIZED ENZYMES

Customized Enzymes

We identify and develop optimized enzymes and biocatalysts that meet complex process and application requirements.

Enzymes
BIOPROCESS DEVELOPMENT

Bioprocess Development – Design For Manufacture

Our Bioprocess Development technology unit operates as a Contract Research Organization (CRO): it develops, optimizes and scales up microbial production processes on behalf of customers. To implement such processes successfully, our experts use the wide range of technical and support skills at their disposal.

Bioprocess Development
STRAIN DEVELOPMENT

Microbial strain development

Based on our industry-leading collection of natural resources and data we identify, develop and optimize microbial production strains that meet our customers’ needs.

Microbial Strain Development

The BRAIN Biotech Group

The BRAIN Biotech Group provides first-class research and development work, specialized production expertise and access to attractive markets. All companies act as self-sufficient entities yet interconnect to synergize in R&D and production in the fields of biotechnology and natural product chemistry.

Latest press releases


Press release, 17 January 2024

Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy

Read press release

Press release, 20 November 2023

Akribion Genomics receives the Hessian Founder Award for its innovative approach to a new cancer therapy

Read press release

Press release, 28 September 2023

BRAIN Biotech AG´s Akribion Genomics team wins first prize in the “BioRiver Boost!” startup competition

Read press release

News & Views

Interested in getting to know more about what drives the company and its people to find biotechnological answers to the questions of today’s industries? Check out our stories here:


18 January 2024

Annual Report 2022/23

Show article

16 January 2024

Specialty enzymes for niche markets

Show article

6 November 2023
Aspergillus niger in a BRAIN Biotech lab

High-performance production strains for enzymes and proteins

Show article


Since 2021 we have been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labour, the environment and anti-corruption

ESG and Sustainability Report

Selected topic:


A collection of icons reffering to alternative proteins

Enabling #futurefood with precision fermentation

Nutrition in industrialized countries will move away from meat and dairy consumption towards alternative sources of protein and foods. These will rely on plants, microorganisms and cell cultures. Biotechnology will be the key enabler. This is where we come in.

Learn more

Share this page